Centaurus Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.58M Sell
8,497
-134
-2% -$24.9K 0.09% 217
2025
Q1
$1.81M Buy
8,631
+124
+1% +$26K 0.11% 180
2024
Q4
$1.51M Buy
8,507
+188
+2% +$33.4K 0.09% 206
2024
Q3
$1.64M Buy
8,319
+1,199
+17% +$237K 0.1% 183
2024
Q2
$1.22M Sell
7,120
-215
-3% -$36.9K 0.08% 217
2024
Q1
$1.34M Sell
7,335
-301
-4% -$54.8K 0.09% 196
2023
Q4
$1.18M Sell
7,636
-863
-10% -$134K 0.09% 215
2023
Q3
$1.27M Buy
8,499
+399
+5% +$59.5K 0.11% 186
2023
Q2
$1.09M Sell
8,100
-6,404
-44% -$863K 0.1% 218
2023
Q1
$2.31M Buy
14,504
+941
+7% +$150K 0.19% 131
2022
Q4
$2.19M Sell
13,563
-876
-6% -$142K 0.21% 126
2022
Q3
$1.94M Buy
14,439
+667
+5% +$89.5K 0.19% 141
2022
Q2
$2.11M Sell
13,772
-3,852
-22% -$590K 0.21% 128
2022
Q1
$2.86M Sell
17,624
-68
-0.4% -$11K 0.23% 115
2021
Q4
$2.4M Buy
17,692
+2,174
+14% +$294K 0.18% 148
2021
Q3
$1.67M Buy
15,518
+118
+0.8% +$12.7K 0.14% 180
2021
Q2
$1.74M Buy
15,400
+3,082
+25% +$347K 0.15% 172
2021
Q1
$1.33M Buy
12,318
+3,769
+44% +$408K 0.13% 188
2020
Q4
$916K Sell
8,549
-710
-8% -$76.1K 0.1% 248
2020
Q3
$811K Sell
9,259
-1,170
-11% -$102K 0.11% 202
2020
Q2
$1.02M Buy
10,429
+2,201
+27% +$216K 0.15% 168
2020
Q1
$627K Buy
8,228
+4,058
+97% +$309K 0.13% 188
2019
Q4
$369K Buy
+4,170
New +$369K 0.05% 353
2018
Q4
Sell
-1
Closed -$105 468
2018
Q3
$105 Sell
1
-13,745
-100% -$1.44M 0.02% 514
2018
Q2
$1.27M Buy
13,746
+12,130
+751% +$1.12M 0.18% 126
2018
Q1
$153K Buy
+1,616
New +$153K 0.04% 365